Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Multiple Sclerosis

  Free Subscription


10.06.2019

1 Brain
3 J Neuroimmunol
2 J Neurol
1 J Neurol Sci
4 Mult Scler
1 N Engl J Med
1 Neurosci Lett
1 PLoS Genet
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Brain

  1. PREZIOSA P, Kiljan S, Steenwijk MD, Meani A, et al
    Axonal degeneration as substrate of fractional anisotropy abnormalities in multiple sclerosis cortex.
    Brain. 2019 Jun 5. pii: 5511700. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Neuroimmunol

  2. KOCH MW, Liu WQ, Camara-Lemarroy C, Zhang Y, et al
    Domperidone-induced elevation of serum prolactin levels and immune response in multiple sclerosis.
    J Neuroimmunol. 2019;334:576974.
    PubMed     Text format     Abstract available

  3. ZURAWSKA A, Mycko MP, Selmaj KW
    Circular RNAs as a novel layer of regulatory mechanism in multiple sclerosis.
    J Neuroimmunol. 2019;334:576971.
    PubMed     Text format     Abstract available

  4. TOMESCU-BACIU A, Johansen JN, Holmoy T, Greiff V, et al
    Persistence of intrathecal oligoclonal B cells and IgG in multiple sclerosis.
    J Neuroimmunol. 2019;333:576966.
    PubMed     Text format     Abstract available


    J Neurol

  5. SODERHOLM J, Yilmaz A, Svenningsson A, Busch K, et al
    Lower risk of multiple sclerosis in patients with chronic hepatitis C: a nationwide population-based registry study.
    J Neurol. 2019 May 31. pii: 10.1007/s00415-019-09397.
    PubMed     Text format     Abstract available

  6. NYE CJS, Wagner A, Kousin-Ezewu O, Jones JL, et al
    A case of anaphylaxis to alemtuzumab.
    J Neurol. 2019;266:780-781.
    PubMed     Text format    


    J Neurol Sci

  7. DE ROQUEMAUREL A, Galli P, Landais A, Avendano S, et al
    Fingolimod for the treatment of multiple sclerosis in French West Indies, a real-world study in patients from African ancestry.
    J Neurol Sci. 2019;402:180-187.
    PubMed     Text format     Abstract available


    Mult Scler

  8. STAMPANONI BASSI M, Iezzi E, Buttari F, Gilio L, et al
    Obesity worsens central inflammation and disability in multiple sclerosis.
    Mult Scler. 2019 Jun 4:1352458519853473. doi: 10.1177/1352458519853473.
    PubMed     Text format     Abstract available

  9. MARRIE RA, Dufault B, Tyry T, Cutter GR, et al
    Developing a crosswalk between the RAND-12 and the health utilities index for multiple sclerosis.
    Mult Scler. 2019 Jun 4:1352458519852722. doi: 10.1177/1352458519852722.
    PubMed     Text format     Abstract available

  10. BROWN JWL, Prados Carrasco F, Eshaghi A, Sudre CH, et al
    Periventricular magnetisation transfer ratio abnormalities in multiple sclerosis improve after alemtuzumab.
    Mult Scler. 2019 Jun 6:1352458519852093. doi: 10.1177/1352458519852093.
    PubMed     Text format     Abstract available

  11. KLINEOVA S, Brandstadter R, Fabian MT, Sand IK, et al
    Psychological resilience is linked to motor strength and gait endurance in early multiple sclerosis.
    Mult Scler. 2019 Jun 7:1352458519852725. doi: 10.1177/1352458519852725.
    PubMed     Text format     Abstract available


    N Engl J Med

  12. IEZZONI LI
    Dangers of Diagnostic Overshadowing.
    N Engl J Med. 2019;380:2092-2093.
    PubMed     Text format    


    Neurosci Lett

  13. G BJ, T R, J O, R PA, et al
    Visual but not verbal working memory interferes with balance in patients after optic neuritis suggestive of multiple sclerosis.
    Neurosci Lett. 2019 Jun 1:134288. doi: 10.1016/j.neulet.2019.134288.
    PubMed     Text format     Abstract available


    PLoS Genet

  14. VILARINO-GUELL C, Zimprich A, Martinelli-Boneschi F, Herculano B, et al
    Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease.
    PLoS Genet. 2019;15:e1008180.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  15. ZHANG S, Su Y, Ying Z, Guo D, et al
    RIP1 kinase inhibitor halts the progression of an immune-induced demyelination disease at the stage of monocyte elevation.
    Proc Natl Acad Sci U S A. 2019;116:5675-5680.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: